BBC News....14 May 2020 02:31
Featured on BBC news this evening after Gilead Sciences has signed non-exclusive voluntary licensing agreements with five generic drug makers based in India and Pakistan on anti-viral drug Remdesivir, seen as a potential therapy for COVID19.
Indian companies Cipla Ltd, Hetero Labs Ltd, Jubilant Life Sciences and Mylan and Pakistani firm Ferozsons Laboratories has signed the commercial agreement that allows the companies to manufacture remdesivir for distribution in 127 countries, including India.
Apologies if this is old news as this may have been in the news around lunchtime today, but thought i would share all the same.
GLA.